D
ecreased myocardial responsiveness to ␤-adrenergic stimulation with hypertrophy 1,2 and failure 3, 4 has been primarily attributed to changes in the ␤-adrenergic receptor. However, in the spontaneously hypertensive rat (SHR), a polygenic model of long-term pressure overload-induced hypertrophy and failure, no decrease in ␤-adrenergic receptor density or affinity was found, 5 suggesting that other factors also may modulate sensitivity. Downregulation of ␣-myosin heavy chain (␣-MHC) with a concomitant upregulation of ␤-MHC has been observed in murine species during myocardial hypertrophy and failure. 6, 7 Until recently, this was not believed to be an important factor in the regulation of myocardial contractility in human myocardium, but recent observations in failing human myocardium indicate that systolic dysfunction was associated with a downregulation of ␣-MHC 8, 9 and upregulation of Na ϩ /Ca 2ϩ exchanger gene expression. 10, 11 A close relation between ␣-MHC and ␤-adrenergic receptor gene expression was found, and it has been suggested that these 2 genes may be coregulated. 8 We have recently demonstrated that treatment with the angiotensin-converting enzyme (ACE) inhibitor captopril causes a progressive upregulation of ␣-MHC gene expression in the SHR and prevents the transition to failure. 12 Although there is generally a parallel relation between expression of mRNA for ␣-MHC and ␤-MHC and protein production, a recent report in aortic banded rats 13 indicates a dissociation between gene expression and protein levels. Therefore, it is important to determine the effects of ACE inhibitor on both expression of mRNA coding for ␣-MHC and on protein production.
In the present study, we examined the relation between the time ACE inhibitor treatment is initiated and its effects on isoproterenol (ISO)-mediated changes in inotropic responsiveness and intracellular calcium ([Ca 2ϩ ] i ) and to quantify changes in ␣-MHC gene expression and protein and Na ϩ /Ca 2ϩ exchanger mRNA with long-term ACE inhibition in hypertrophied and failing myocardium from the SHR.
Methods

Animal Model
Forty-three male SHR and 12 Wistar-Kyoto rats (WKY) were purchased from Taconic. Rats were housed 2 per cage and fed standard rat chow and allowed free access to water. Captopril was added to drinking water at a concentration of 2 g/L (CAP Rx ), which has been shown to be effective in preventing hemodynamic impairment associated with chronic hypertrophy in the SHR. 14 Groups of SHR had CAP Rx initiated at 12, 18, and 21 months of age (SHR-Rx 12 , SHR-Rx 18 , and SHR-Rx 21 , respectively). Control groups included untreated age-matched SHR and WKY and 12-month CAP Rx -treated WKY. Animals were monitored with measurements of body weight and blood pressure (peak systolic arterial blood pressure was measured in the conscious animals by the tail-cuff method). Animals were also observed for evidence of tachypnea and labored respiration; when these findings became evident, animals were killed and papillary muscles were studied. An additional group of SHR were CAP Rx , starting at the onset of failure (SHR-F-Rx). All other animals not demonstrating symptoms of respiratory distress were studied at 24 months of age. All procedures and animal care were in accordance with institutional guidelines for animal research at the Boston VA Medical Center and Boston University School of Medicine.
Experimental Preparation
Hearts were quickly removed, and the left ventricular (LV) anterior papillary muscle was dissected free and mounted vertically in a 50-mL glass chamber containing oxygenated Krebs-Henseleit solution at 28°C and stimulated at a rate of 0.2 Hz as previously described. [15] [16] [17] The upper end of the muscle was attached to a low-inertia DC pen motor (300B lever system, Cambridge Technologies Inc). A digital computer with an analog/digital interface allowed control of either tension or length of the preparation; the data were stored on disk for later analysis. After mounting, muscles were allowed to equilibrate and then gradually stretched to the peak of the active force versus length curve (L max , defined as the muscle length resulting in the peak active stress). At L max , isometric contraction parameters of 5 twitches were determined and averaged and force normalized for muscle crosssectional area. There were no significant differences in muscle cross-section area (all muscles averaged 0.94Ϯ0.05 mm 2 ).
Aequorin Studies
Aequorin was loaded into the muscle preparations by the macroinjection technique as previously described. 16 After loading, muscles were allowed to equilibrate for 90 to 120 minutes until a steady state was achieved. Light and force signals were recorded and analyzed by a digital recording system developed in our laboratory. The fractional luminescence method 18 was used to provide calibration for comparison of light signals among groups.
Experimental Protocol
After aequorin loading and equilibration, muscle preparations were exposed to concentrations of Ca 2ϩ (0.6, 1.2, 2.5, and 5 mmol/L) for 10 minutes each, a period during which active force stabilized. The muscles were then allowed to reequilibrate at the baseline Ca 
Tissue Isolation and Preparation
After removal of the papillary muscles, the heart was dissected into atria, LV, and right ventricles (RV). Tissues were gently blotted and weighed. LV samples were quickly frozen and stored in liquid nitrogen. LV and RV weight-normalized by body weight were used as indexes of ventricular hypertrophy.
Myosin Isozyme Studies
The methods for tissue preparation, myosin extraction, and electrophoretic separation of isomyosins have been previously described. 19 Briefly, myosin was extracted from Ϸ200 mg of the frozen LV. Isomyosins were separated by electrophoresis on polyacrylamide gels, under nondissociating conditions as described by Hoh et al. 20 The gels were fixed, stained with Coomassie blue R 250, then scanned on a Joyce Lobel scanning densitometer at 520 nm. The relative proportions of the isomyosins present were obtained from the gel scans by measuring the area under each peak to obtain a final estimate of the proportion of V 1 (heavy chain-␣) and V 3 (heavy chain-␤) isomyosins present.
Analysis of Cardiac Na
؉
/Ca 2؉ Exchanger and ␣-MHC mRNA Levels
Frozen samples of LV tissue were processed and the RNA extracted for Northern blot analysis of Na ϩ /Ca 2ϩ exchanger and ␣-MHC mRNA expression as previously published. 7, 12 Briefly, RNA was isolated from cardiac tissue by the method of Chomczynski and Sacchi. 21 Ten micrograms of total RNA was size-fractionated by electrophoresis and transferred to nylon membranes (Genescreen Plus; Dupont NEN). A rat cDNA for Na ϩ /Ca 2ϩ exchanger was labeled with 32 P␣-dCTP by the random hexamer priming method and hybridized to nylon blots for 18 to 24 hours at 42°C. Probes for ␣-MHC and 18S ribosomal RNA were end-labeled synthetic oligonucleotides previously described. 22 Washed blots were exposed to film, and the signals were quantified by a densitometric system (GS700, BioRad). Blots were probed with a 32 P-labeled oligonucleotide complementary to 18S ribosomal RNA. Levels of mRNA reported here are normalized to the level of 18S rRNA.
Statistical Analysis
Data from the SHR-F, SHR-NF, and WKY groups were compared with the use of 1-way ANOVA with replication. A 2-way ANOVA was used to examine group and treatment effects. The NewmanKeuls multiple-sample comparison test or Tukey's procedure 23 was used to localize differences where appropriate. Differences were considered significant at PϽ0.05. Data are expressed as meanϮSD.
Results
Animal Weights, LV Weight, Heart Chamber Ratios, and Blood Pressure Changes CAP Rx decreases cardiac hypertrophy, as indicated by decreases in LV/body weight (BW) and RV/BW in comparison to untreated SHR (Table 1) . In CAP Rx , SHR RV/BW was not significantly different from the WKY, whereas LV/BW was elevated relative to untreated WKY (PϽ0.05). Peak systolic arterial pressure was higher in untreated SHR before CAP Rx and decreased with CAP Rx but remained higher than WKY. ] i , and ϩd/dt increased with ISO, whereas peak at L max was only slightly increased and TP decreased. In SHR-NF and SHR-F, despite an increase in [Ca 2ϩ ] i , peak and ϩd/dt fell in response to ISO, whereas TP decreased (PϽ0.05 SHR-NF and SHR-F versus WKY). In contrast, in SHR-Rx 12 , ISO increased peak and peak ϩd/dt, whereas TP decreased (NS SHR-Rx 12 versus WKY). CAP Rx of SHR starting at 21 months of age resulted in a small increase in ϩd/dt, whereas peak and TP deceased slightly. Figure 3 . Peak , ϩd/dt, and the Ca 2ϩ signal peak increased in all groups with and without CAP Rx when the [Ca 2ϩ ] o of the bath was increased from 0.6 to 5.0 mmol/L, whereas TP and TPLϩRL 1/2 did not change.
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the Na ϩ /Ca 2ϩ exchanger mRNA levels in SHR Rx to levels seen in WKY.
Isomyosin Distribution and ␣-MHC Gene Expression
The distribution of LV myosin isozymes from CAP Rx and untreated SHR from the same hearts in which the papillary muscles were studied is shown in Table 3 . There was a significant increase in the proportion of V 1 to V 3 isozyme with CAP Rx . The relative increase in V 1 MHC composition of LV was greatest in the 12-month CAP Rx group and increased to a lesser extent when CAP Rx was initiated at 18 and 21 months of age, respectively. The inotropic responsiveness to ISO was proportional to the relative V 1 MHC content. There was a significant positive correlation between ϩd/dt and ␣-MHC mRNA expression in response to ISO at 10 Ϫ6 mol/L (rϭ0.88, PϽ0.05). CAP Rx upregulated ␣-MHC mRNA in the WKY as well as in SHR ( Figure 5 ).
Discussion
The present study demonstrates that long-term CAP Rx restores myocardial inotropic responsiveness to ISO, in association with reversal of changes in ␣-MHC and Na ϩ /Ca 2ϩ exchanger gene expression, in the SHR during the transition to failure. Impaired responsiveness to ␤-adrenergic stimulation is one of the earliest changes reported with myocardial hypertrophy 1,2,24 and failure. 3, 4, 25, 26 Recent observations in failing human myocardium indicate that systolic dysfunction was associated with a downregulation of ␣-MHC 8,9 and upregulation of Na ϩ /Ca 2ϩ exchanger gene expression. 10, 11 In acute myocardial infarction and aortic banding models, ISO induces a blunted but nevertheless positive inotropic response, [27] [28] [29] whereas in the SHR with long-standing hypertrophy, ISO decreases isometric force at L max . ACE inhibition has been shown to partially improve responsiveness to ISO in the infarcted 27 but not the aortic-banded myocardium. 28 In the present study, 3 to 12 months of CAP Rx restored the positive inotropic responsiveness of the SHR myocardium to ISO. Previous studies have noted impaired inotropic responsiveness of hypertrophied myocardium to ISO without ␤-adrenergic receptor changes. 2 Our laboratory has demonstrated a depressed inotropic response of LV papillary muscles from hypertrophied and failing SHR hearts to ISO but not Ca 2ϩ (Reference 16), despite an increase in LV ␤-adrenergic receptor density with failure 5 and an increase in the peak transient intracellular Ca 2ϩ . 16 These findings suggest that depressed LV inotropic responsiveness is unlikely to be mediated by downregulation of the ␤-receptors and may implicate postreceptor mechanisms, such as altered Ca 2ϩ dynamics or myofilament responsiveness.
Responsiveness of cardiac myofilaments to Ca 2ϩ may be modulated by a change in kinetics of the actin-myosin cross-bridge turnover 30 or may be influenced in vivo by a number of intracellular effectors, including pH and cAMP 31 ; the effects of these factors on V 1 and V 3 myosin may differ. 32 In CAP Rx SHR, the relative proportion of V 1 myosin isozyme present was associated with improved inotropic responsiveness to ISO. Epinephrine has been shown to increase crossbridge cycling rate in V 1 to a greater extent than in V 3 myosin, 33 since cAMP does not increase myosin ATPase activity in myocardium containing V 3 myosin. 32 Depressed myocardial contractile sensitivity to catecholamines has been related to the concentration of V 3 myosin isozyme. 33, 34 Dibutyryl cAMP, which exerts a positive inotropic effect without stimulation of the ␤-receptor, has also been shown to have a smaller inotropic response in LV papillary muscles with higher V 3 levels from aortic-constricted rats 29 and from rats with large myocardial infarctions 35 relative to controls. Thus, in the SHR, improved inotropic responsiveness with captopril may be mediated by the captopril-induced increase in V 1 . It is interesting to note that CAP Rx increased the expression of ␣-MHC mRNA by Ϸ2-fold not only in the SHR but also in the normotensive WKY, in which there was no significant lowering of arterial blood pressure. Thus, captopril affects pretranslational regulation of MHC composition; the finding that increased expression of V 1 myosin in the WKY, in which blood pressure was not altered, suggests that this is not directly related to its blood pressure-lowering effects. Thus, CAP Rx appears to reverse genetic factors responsible for hypertrophy and age-associated changes in ␣-MHC expression.
The Na ϩ /Ca 2ϩ exchanger also may affect myocardial responsiveness, and Na ϩ has been shown to be required for the positive inotropic actions of ISO. 36 In atrial tissue, changing from a normal extracellular Na ϩ concentration to a Na ϩ -free medium not only resulted in a negative inotropic effect of ISO but also increased TP and relaxation time of the isometric contraction, 36 physiological responses that are similar to those seen in hypertrophied SHR myocardium. Recent studies in failing human myocardium indicate that systolic dysfunction is associated with upregulation of Na ϩ /Ca 2ϩ exchanger gene expression. 10, 11 This may be in response to depressed sarcoplasmic reticulum function and impaired regulation of diastolic Ca 2ϩ levels. 10 It is possible that upregulation of this pathway in hypertrophied myocardium may be a compensatory response providing an alternative pathway for mobilizing intracellular Ca 2ϩ (eg, reverse Na ϩ /Ca 2ϩ exchange). 37 In isolated sarcolemmal vesicle preparation from rat heart, angiotensin II has been shown to directly stimulate activity of the Na ϩ /Ca 2ϩ exchanger 38 ; captopril may therefore reduce angiotensin-mediated effects on the exchanger. In the present studies, expression of Na ϩ /Ca 2ϩ exchanger was upregulated during the transition to failure and decreased with CAP Rx cAMP, and myosin shifts, findings not seen in compensated SHR treated with captopril, suggest that several factors may be required for the positive inotropic response to catecholamines and may contribute to contractile depression seen with failure. Because both calcium handling and downstream myofilament responsiveness are affected, the present results demonstrate that captopril can modulate transcriptional regulation of expression of multiple cardiac genes to reverse hypertrophic changes that effect contractility and enhance myocardial ␤-adrenergic responsiveness. 
